Even a year after a #heartattack, patients are.. - 1時間前  @AstraZeneca

Even a year after a #heartattack, patients are still at risk of experiencing another CV event. We continue to foster stronger relationships between healthcare professionals and patients to bridge the gap between data and life-changing outcomes for patients. #AHA19
カテゴリー:医療

Advances in data science can help us re-think .. - 7時間前  @AstraZeneca

Advances in data science can help us re-think clinical trials, enhancing current practice and finding new ways to discover and develop potential new medicines. Three of our data science experts explain how in this new podcast:
カテゴリー:医療

We’re prioritizing the importance of fostering.. - 10時間前  @AstraZeneca

We’re prioritizing the importance of fostering safe, inclusive and respectful work environments at AstraZeneca and join the @UNHumanRights LGBTI Standards of Conduct for Business to stand with companies who are tackling discrimination against the #LGBTI community. @free_equal
カテゴリー:医療

Men and women living with #T2D experience diff.. - 1日前  @AstraZeneca

Men and women living with #T2D experience different levels of risk for complications like cardiovascular disease and hospitalisation for #heartfailure. Our research at #AHA19 aims to better understand these risks, so we can help develop personalised solutions to improve outcomes.
カテゴリー:医療

Among myocardial infarction (MI) survivors, 14.. - 1日前  @AstraZeneca

Among myocardial infarction (MI) survivors, 14-33% of patients will have another MI or fatal coronary heart disease within five years. New data at #AHA19 will help us better understand how we can help lower the risk of secondary events.
カテゴリー:医療

We are striving to advance clinical outcomes i.. - 2日前  @AstraZeneca

We are striving to advance clinical outcomes in patients living with #cardiovascular disease. Let’s help support patients as they manage the additional cardiovascular, renal and metabolic complications that occur along the way. #AHA19
カテゴリー:医療

Knowing the related risks of diabetes includin.. - 3日前  @AstraZeneca

Knowing the related risks of diabetes including chronic #kidney disease & #heartfailure can help us better manage the disease and associated complications. #DiabetesAwarenessMonth is a reminder we can turn the tide by seeking support early on.
カテゴリー:医療

#Pancreaticcancer may go undetected until it h.. - 3日前  @AstraZeneca

#Pancreaticcancer may go undetected until it has spread and become metastatic. At this late stage, it is more difficult to treat. Early diagnosis is essential for improving patient outcomes in pancreatic cancer. #PancreaticCancerAwarenessMonth
カテゴリー:医療

We’re driving research into potential SCLC tre.. - 4日前  @AstraZeneca

We’re driving research into potential SCLC treatments. Additional options are needed to address low cancer survival rates and the critical need to improve patient outcomes. #LCSM
カテゴリー:医療

Understanding the day-to-day experience of pat.. - 4日前  @AstraZeneca

Understanding the day-to-day experience of patients living with #diabetes can help us provide the support they need. Our goal is to help HCPs prevent early cardio-renal complications, creating a seamless pathway for patients to live healthier lives. #WorldDiabetesDay
カテゴリー:医療

Data presented at #AHA19 showcased our ongoing.. - 2時間前  @AstraZeneca

Data presented at #AHA19 showcased our ongoing commitment to putting patients first. We are partnering with healthcare professionals with the aim to create meaningful change in how #heartfailure is managed for patients living with the disease and its comorbidities, such as #T2D.
カテゴリー:医療

“My mantra my whole life was – whatever the pr.. - 9時間前  @AstraZeneca

“My mantra my whole life was – whatever the problem, there’s always a path forward.” For patients with #heartfailure, we are helping to provide patients the right support to better manage their disease and keep moving forward with ease. #AHA19
カテゴリー:医療

Once doctors have established whether a patien.. - 1日前  @AstraZeneca

Once doctors have established whether a patient has SCLC or NSCLC, they can test to identify the molecular features of their #lungcancer, called #biomarkers. These are integral to understanding patients’ genetic makeup and matching them to appropriate therapies. #LCAM #LCSM
カテゴリー:医療

An estimated 40% of patients who have been hos.. - 1日前  @AstraZeneca

An estimated 40% of patients who have been hospitalised for #heartfailure have #T2D. Right now, at #AHA19 we are connecting with healthcare professionals and experts to advance clinical discussions in bringing more options to patients.
カテゴリー:医療

It’s a fact: up to 1 in 5 people who have expe.. - 2日前  @AstraZeneca

It’s a fact: up to 1 in 5 people who have experienced a heart attack may go on to have another within one year. More can be done to reduce this risk in patients across the globe, and at #AHA19, we present data with the aim to improve outcomes for patients.
カテゴリー:医療

Despite medical advances, #heartfailure remain.. - 2日前  @AstraZeneca

Despite medical advances, #heartfailure remains as life-threatening as some of the most common cancers in men (prostate and bladder) and women (breast). #AHA19 is our opportunity to present our latest research findings to help tackle this condition.
カテゴリー:医療

From new technologies and novel platforms to p.. - 3日前  @AstraZeneca

From new technologies and novel platforms to patient perspectives and innovation ideas, scientists from across BioPharmaceuticals R&D gathered at the Global Science Symposium to discuss, learn and be inspired. Our scientists describe the symposium in just one word...
カテゴリー:医療

Today, we joined @CRUKresearch for the opening.. - 3日前  @AstraZeneca

Today, we joined @CRUKresearch for the opening of the Functional Genomics Centre in #Cambridge. Through our collaboration, we aim to deepen understanding of cancer biology and accelerate development of treatments for patients with #cancer. Full video here:
カテゴリー:医療

We have signed an agreement with Omron Healthc.. - 4日前  @AstraZeneca

We have signed an agreement with Omron Healthcare to help improve lives and contribute to a better society through translating science & technology to enhance the whole patient experience, from diagnosis to treatment and post-treatment.
カテゴリー:医療

We believe #machinelearning and #deeplearning .. - 4日前  @AstraZeneca

We believe #machinelearning and #deeplearning can help us make a big change in how we design new medicines. But collaboration –internally and externally – is essential to realising the potential of data science and #AI. Watch more:
カテゴリー:医療